Home >> About

News & Events

Philadelphia, PA (10/21/2009) - The nation’s economic stimulus package has provided a significant boost to research, and Temple has benefited through the acquisition of more than $11 million in funding — including three highly competitive NIH challenge grants. 

Philadelphia, PA (07/06/2009) - Pharmacy is all about maximizing molecules to become therapeutic agents — when done successfully, the result is a drug that can make a profound difference in the lives of patients. Drugs that ultimately reach your medicine cabinet, however, are the product of a rigorous process that begins in laboratories such as the Moulder Center for Drug Discovery Research.

Temple University’s School of Pharmacy has landed a top Wyeth Pharmaceuticals  Wyeth Pharmaceuticals Latest from The Business Journals Center for Animal Health Innovation names a CEO, starts proof-of-concept grant programNew Drexel degree trains drug researchersWith Keystone buy, summer sales hit 0M Follow this company researcher to serve as director of the school’s new Center for Drug Discovery Research.

Magid Abou-Gharbia has joined Temple after spending 26 years at Wyeth Pharmaceuticals, where he led a research team directly involved in the discovery and development of five Wyeth products now in the market.

In the early 1980s, the quest for a better anti-depressant was the focus of intense research aimed at designing novel serotonin re-uptake inhibitors. While most scientists focused solely on serotonin as a target however, the medicinal chemists’ team at Wyeth Pharmaceuticals, led by Magid Abou-Gharbia, was determined to go after two neurotransmitters, serotonin and norepinephrine.


Temple University
Moulder Center for Drug Discovery Research

Temple University School of Pharmacy
3307 N Broad Street
Philadelphia, PA 19140